Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,280.88
+3.37(+0.06%)
Dow
38,576.53
-109.79(-0.28%)
Nasdaq
16,819.79
+84.78(+0.51%)
Bitcoin USD
69,259.20
+938.23(+1.37%)
CMC Crypto 200
1,499.26
+31.32(+2.13%)

BMY Jan 2025 45.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.3800

+0.4400

(+22.68%)

As of 10:16AM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....